Evidence map›Paper›PMID 41796328›Full record

ArticleAnnals of clinical microbiology and antimicrobials2026

Comparative evaluation of Anyplex™ MTB/NTM, Xpert MTB/RIF ultra, culture, and microscopy for the diagnosis of pediatric tuberculosis using gastric aspirates.

Matúš Dohál, Věra Dvořáková, Michaela Hromádková, Peter Kunč, Jaroslav Fábry, Igor Porvazník, Ivan Solovič, Karolína Doležalová, Michaela Krivošová, Juraj Mokrý

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in Annals of clinical microbiology and antimicrobials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Matúš DohálBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University, Bratislava, Malá Hora 4C, 036 01, Martin, Slovakia. matus.dohal@uniba.sk.
Věra DvořákováNational Institute of Public Health, Prague, Czech Republic.
Michaela HromádkováNational Institute of Public Health, Prague, Czech Republic.
Peter KunčClinic of Pediatric Respiratory Diseases and Tuberculosis, National Institute of Pediatric Tuberculosis and Respiratory Diseases, Jessenius Faculty of Medicine in Martin, Comenius University, Dolný Smokovec, Bratislava, Slovakia.
Jaroslav FábryClinic of Pediatric Respiratory Diseases and Tuberculosis, National Institute of Pediatric Tuberculosis and Respiratory Diseases, Jessenius Faculty of Medicine in Martin, Comenius University, Dolný Smokovec, Bratislava, Slovakia.
Igor PorvazníkNational Institute of Tuberculosis Lung Diseases and Thoracic Surgery, Vyšné Hágy, Slovakia.
Ivan SolovičNational Institute of Tuberculosis Lung Diseases and Thoracic Surgery, Vyšné Hágy, Slovakia.
Karolína DoležalováDepartment of Paediatrics of the First Faculty of Medicine, Thomayer University Hospital, Charles University, Prague, Czech Republic.
Michaela KrivošováBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University, Bratislava, Malá Hora 4C, 036 01, Martin, Slovakia. michaela.krivosova@uniba.sk.
Juraj MokrýDepartment of Pharmacology, Jessenius Faculty of Medicine in Martin, Comenius University, Bratislava, Slovakia.

Funding

Agentúra na Podporu Výskumu a Vývoja 18-0084NIPH 75010330Vedecká Grantová Agentúra MŠVVaŠ SR a SAV 1/0036/26Vedecká Grantová Agentúra MŠVVaŠ SR a SAV 1/0093/22
6 · The paper itself

Abstract

backgroundPaediatric tuberculosis (TB) diagnosis remains a challenge due to the paucibacillary nature of the disease, resulting in 51.00% of TB cases remaining undiagnosed, rising to 58% in children under five years of age.

methodsThis study evaluates the effectiveness of different microbiological methods (Xpert

resultsThe highest sensitivity was observed with the Anyplex MTB/NTM assay (38.94%). Interestingly, Xpert MTB/RIF Ultra exhibited lower sensitivity than culture (16.67% versus 21.27%). Considering all methods together, the positivity was not significantly associated with age. The overall positivity rate of all diagnostic methods combined was higher in children under five years (46.7%) and adolescents aged 16-18 years (54.2%) compared with those aged 6-15 years (31.2%). Similarly, the sensitivity of individual diagnostic methods (except Xpert MTB/RIF Ultra) followed the same trend.

conclusionThese data indicate that gastric aspirate microbiology provides only moderate confirmation of paediatric TB in routine practice, and that nucleic acid amplification-based technologies (NAAT) should be used as part of a complementary diagnostic strategy alongside culture and smear microscopy, with culture remaining essential for drug susceptibility testing. Because NAAT platforms were applied in different centre-specific cohorts, the findings should be interpreted as real-world yields rather than a head-to-head comparison, and future work should prioritise standardised sampling and evaluation of non-invasive alternatives (e.g., stool) across age groups.

Indexed as

Molecular Diagnostic TechniquesMycobacterium tuberculosisTuberculosisAdolescentChildChild, PreschoolCzech RepublicFemaleGastric JuiceHumansInfantMaleMicroscopyNucleic Acid Amplification TechniquesSensitivity and SpecificitySlovakiaAnyplex™ MTB/NTMDiagnosticsGastric aspiratePediatric tuberculosisSensitivity

Identifiers

PMID41796328
PMCPMC13081516

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.